Eric J. Rellinger

ORCID: 0000-0003-2557-5719
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroblastoma Research and Treatments
  • Ubiquitin and proteasome pathways
  • Cancer, Hypoxia, and Metabolism
  • Signaling Pathways in Disease

University of Kentucky
2024-2025

Markey Cancer Center
2025

MYCN-amplification is a genetic hallmark of ~40% high-risk neuroblastomas (NBs). Altered glycosylation common feature adult cancer progression, but little known about how signatures such as alter profiles. Herein, matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) revealed increased core fucosylated glycan abundance within neuroblast-rich regions human MYCN-amplified NB tumors. GDP-mannose 4,6-dehydratase (GMDS) responsible for the first-committed and...

10.1038/s41388-025-03297-0 article EN cc-by-nc-nd Oncogene 2025-02-16

<title>Abstract</title> <italic>MYCN-</italic>amplification is a genetic hallmark of ~ 40% high-risk neuroblastomas (NBs). Altered glycosylation common feature adult cancer progression, but little known about how signatures such as <italic>MYCN</italic>-amplification alter profiles. Herein, matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) revealed increased core fucosylated glycan abundance within human <italic>MYCN-</italic>amplified NB tumors. GDP-mannose...

10.21203/rs.3.rs-4720665/v1 preprint EN cc-by Research Square (Research Square) 2024-08-11
Coming Soon ...